Furthermore, clinical studies and genomic analysis have confirmed that LRP6 genetic variants contribute to the progression of hypertension, atherosclerosis, hypercholesterolemia, and other diseases [24,57]. Here, LRP6 is linked to familial hypercholesterolemia.